Companies

Jaguar Health, Inc.

JAGX · CIK 0001585608 · operating

$0.82-7.95%Last updated Mar 2, 8:48 PM

Key Statistics

Valuation

Market Cap$3.34M
P/E
Fwd P/E-0.14
PEG
P/S0.28
P/B0.94
EV/EBITDA-1.05
EV/Rev2.77

Profitability

Gross Margin
Op. Margin-263.76%
Net Margin-329.30%
ROE
ROA-72.05%
FCF Margin-251.52%

Financial Health

Current Ratio1.63
Debt/Equity
Free Cash Flow-$29.40M
Div. Yield

Growth & Other

Revenue Growth
EPS Growth-7201.12%
Beta0.12
52W High$15.48
52W Low$0.56

About Jaguar Health, Inc.

Jaguar Health, Inc. (JAGX) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $4 million, Jaguar Health, Inc. is a micro-cap company. The stock currently trades at $0.82, down 7.95% today, with a 52-week range of $0.56–$17.30.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-130.69$-130.69-7201.1%
2023$-1.79$-1.79+95.1%
2022$-36.18$-36.18-2966.1%
2021$-1.18$-1.18
2020
2019
2018
2017
2016
2015

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2024-12-312025-03-310000950170-25-047184SEC ↗
2023-12-312024-04-010001558370-24-004439SEC ↗
2022-12-312023-03-240001558370-23-004572SEC ↗
2021-12-312022-03-110001558370-22-003435SEC ↗
2020-12-312021-03-310001558370-21-003811SEC ↗
2019-12-312020-04-030001558370-20-003581SEC ↗
2018-12-312019-04-100001558370-19-002908SEC ↗
2017-12-312018-04-090001047469-18-002654SEC ↗
2016-12-312017-02-150001047469-17-000684SEC ↗
2015-12-312016-03-290001047469-16-011700SEC ↗